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Overview
The acquisition of increasing numbers of bacte-
rial whole-genome sequences (>50) has coincided
with the development of a range of technologies
to study the function of genes on a genome-wide
scale, which are grouped under the broad head-
ing of functional genomics. In terms of bacterial
pathogenesis, one of the current major research
interests lies in deﬁning the complement of genes
that determine virulence (the virulome) and how
these genes may be coordinately regulated (the reg-
ulome) and expressed at the level of mRNA (the
transcriptome) and protein (the proteome). Bacte-
rial virulence may be deﬁned as the appropriate
temporal and spatial expression of overlapping sub-
sets of genes necessary for a particular phase of
infection, in response to speciﬁc environmental sig-
nals encountered within the host.
A rapidly growing literature using microarrays
for bacterial functional genomics has conﬁrmed the
reality and robust nature of spotted DNA glass-
slide microarrays for small genome organisms. The
relative biological simplicity of bacterial genomes
and thus the straightforward nature of the design
and construction of whole genome microarrays
facilitates the analysis of bacterial whole genomes
by both comparative genomics and gene expres-
sion proﬁling. Together they provide a powerful
approach to the deﬁnition of genes important in
pathogenesis and offer the prospect of useful tar-
gets for rational design of new drugs and vaccine
candidates for bacterial pathogens.
Post-genome biology divides into observational
biology to drive hypotheses, and experimen-
tal genomics that use some of the new tools
to test hypotheses. Microarrays will potentially
deliver both. There is a prominent place for
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hypothesis-generating (observational) experiments
in genome biology, which implicitly test our cur-
rent understanding of gene expression, regula-
tion and function. This BµG@S 2002 meeting
on bacterial microarrays showed the value of
both approaches in comparative and functional
genomics of bacteria. In this new era of func-
tional genomics, scientists of different disciplines
and skills are increasingly being asked to work
together — molecular biologists, cell biologists,
clinical scientists, computer scientists, statisticians,
mathematicians and engineers. The meeting illus-
trated the beneﬁts of such interdisciplinary col-
laborations and highlighted the progress made by
a number of academic groups around the UK
studying bacterial pathogens using whole-genome
microarrays and accessing newly developed math-
ematical and statistical data analysis tools. Despite
the relative simplicity of the organism, the task
faced by bacteriologists is immense. The abil-
ity to study every bacterial strain, or monitor
expression proﬁles with time under every con-
dition is clearly neither a practical proposition
nor a well-considered scientiﬁc goal. With limited
resources and ﬁnances more focused experiments
are required. This necessitates collaborative efforts
and data comparisons from different experiments,
e.g. DNA damage responses, the SOS response,
stress responses and in vivo expression proﬁles,
such as during macrophage exposure, or conditions
that may mimic some aspect of the host environ-
ment. Common-format databases for data compar-
ison will accelerate and facilitate this process and
are being established (Witney and Hinds, p. 369).
BµG@S 2002
The general aim of the BµG@S 2002 meeting was
to present the results of experiments using bac-
terial microarrays made by a multi-collaborative
and multi-disciplinary research group: the micro-
bial pathogen microarray facility (BµG@S) based
at St George’s Hospital Medical School, Lon-
don. BµG@S was funded by The Wellcome
Trust in 2001 under the ‘Resources for Func-
tional Genomics Initiative’. Its main aim is to
construct whole-genome arrays for 12 bacterial
pathogens in 2 years (2001–2003) and to make
them available over a 5 year period to an exten-
sive network of collaborative academic research
groups around the UK (Hinds et al., p. 333;
see also http://bugs.sghms.ac.uk). Microarrays
for Mycobacterium tuberculosis, Campylobacter
jejuni,Haemophilus inﬂuenzae, Streptococcus pneu-
moniae and Yersinia pestis are already in use at
BµG@S and most of the presentations at the meet-
ing therefore related to these pathogens. Many of
the topics presented at the meeting are covered in
this supplement as conference reviews on a sub-
ject/pathogen basis.
There were over 150 delegates invited from the
collaborating groups. The meeting opened with
an introduction about the collaborative ethos of
BµG@S and how this unique microarray resource
was established (Dr Philip Butcher, St George’s
Hospital Medical School, London). A review
of the potential of microarrays in bacterial func-
tional genomics was then presented by Professor
Brendan Wren (London School of Hygiene and
Tropical Medicine) in which the latest ‘headline’
ﬁndings in bacterial pathogenicity were explored
(Wren, p. 330). This was followed by an overview
of the multi-collaborative network of BµG@S and
its progress with making and utilizing the microar-
rays (Hinds et al., p. 333). The keynote speaker
was Dr Rob Fleischmann from the Institute of
Genomic Research (TIGR), USA, who talked
about the NIAID-sponsored Pathogen Functional
Genomics Resource Centre at TIGR, and also pre-
sented research results on the Streptococcus pneu-
moniae competence system.
The meeting’s subject matter was structured into
three main areas: comparative genotyping, gene
expression and data analysis (see below). A fourth
and ﬁnal session consisted of contributions from
representatives of other UK microbial genomics
resources (Dr Al Ivens from the Sanger Institute
Pathogen Sequencing Unit and Dr Tom Free-
man from the MRC HGMP-RC), who talked
about the genomic resources available to the aca-
demic community. Also, other collaborating aca-
demic research groups that make and use microbial
microarrays presented their research and described
their microarray facilities. This included Dr Colin
Smith (UMIST, Manchester), who talked about
the Streptomyces microarray and presented cluster
analysis of gene expression data during develop-
mental and metabolic transitions in Streptomyces.
Dr Jay Hinton (Institute of Food Research, Nor-
wich) presented array data to show that point muta-
tions in polynucleotide phosphorylase (PNPase) of
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Salmonella enterica affected the expression of sub-
sets of genes, including the SPI1 and SPI2 viru-
lence genes, indicating a role for PNPase in a novel
form of global virulence gene regulation.
Comparative genomics
Microarray experiments broadly divide into those
in which genomic DNA is used in hybridizations,
and expression studies using RNA-derived cDNA.
Not surprisingly, due to simpler analysis, the for-
mer has advanced most quickly. The compara-
tive genomics section of the meeting highlighted
the use of arrays in Mycobacteria, Yersinia and
Campylobacter species. Subjects covered included
bacterial taxonomy, genome indexing and pheno-
typic correlation in clinical isolates for virulence
gene mapping. A well-studied example was the
partially overlapping plasmid-based whole-genome
C. jejuni microarray, which revealed extensive
genetic diversity amongst clinical strains, with at
least 21% of genes being dispensable. These genes
were predominantly associated with the biosynthe-
sis of surface structures, including ﬂagella, lipo-
oligosaccharide and the capsule, as well as those
responsible for iron acquisition, DNA restriction
and sialylation (Dorrell et al., p. 338). Also of par-
ticular note were the immediate public health appli-
cations of bacterial arrays in human (M. tubercu-
losis) and animal (M. bovis) pathogen molecular
epidemiological studies and in community outbreak
investigations (respectively, Inwald et al., p. 342
and Shaﬁ et al., p. 362).
Clearly, arrays are powerful tools but do not
comprehensively probe entire genomes of all new
strains, since arrays contain elements (spotted
DNA) from selected sequenced ‘reference’ strains
and therefore only detect deleted genes in the
test strains. Without whole-genome sequencing of
every isolate, microarrays are thus limited to known
sequenced genes. Constructing pan-genus or pan-
species arrays representative of all sequenced genes
in different strains or species on one array goes
some way towards meeting such limitations and
was highlighted as a priority for BµG@S (Wren,
p. 330). A major challenge, therefore, with bac-
terial genomes is to deﬁne gene additions; this
may be accomplished by sequencing subtractive
hybridization products between references and test
strains for subsequent inclusion on arrays. Another
approach might be to assume that deletion sites
detected on arrays might also be sites for inser-
tions; PCR ampliﬁcation across deletions therefore
may reveal inserted sequences.
Gene expression
Gene expression studies are more difﬁcult to per-
form and analyse than comparative DNA hybridiza-
tions. The variation introduced into such experi-
ments, which was fully explored in this meeting,
derives from biological as well as experimental
variation. Subtle differences in bacterial growth
rate, cell density and environmental conditions may
inﬂuence gene expression proﬁles. Emphasis was
placed on the extraction of ‘biologically meaning-
ful’ RNA and the avoidance of mRNA expression
artefacts due to sample preparation. A range of
talks on gene expression proﬁling during various
in vitro conditions were presented (see confer-
ence reviews). Signiﬁcantly, the use of chemostat
cultures of M. tuberculosis (James et al., p. 345)
showed the value of such systems in reducing
the biological variability in complex heterogeneous
batch cultures of bacteria and also in permitting
a more robust statistical analysis of the data pro-
duced. Examples of microarrays to dissect the
bacterial regulome and functionally analyse pro-
moter elements were presented by the use of tran-
scriptional regulatory mutants in M. tuberculosis
(Kendall et al., p. 352 and Stewart et al., p. 348),
the response regulator pnpR of Streptococcus pneu-
moniae (McCluskey et al., p. 366) and mutants of
alternative sigma factors ﬂiA and rpoN in C. jejuni
(Dorrell et al., p. 338).
Other issues relating to expression data were
raised during the meeting. These included the abil-
ity to overlay expression data onto both genome
structure and metabolic pathways, so as to be
able to experimentally conﬁrm operon organiza-
tion or deduce the use of certain metabolic path-
ways, respectively. Also discussed was the issue
that small changes in mRNA may produce big
changes in phenotype, and that the often-used two-
fold change cut-off values should be viewed as
arbitrary levels for ease of data handling, and not
as the value above which biological signiﬁcance
may be inferred. Although it is reported increas-
ingly in the literature that fold-changes in mRNA
of 1.5–1.9 can be statistically measured, such
Copyright  2002 John Wiley & Sons, Ltd. Comp Funct Genom 2002; 3: 326–329.Conference Editorial: Pathogen microarrays 329
accuracy remains a challenge for most microarray
experiments. However, without accurate measure-
ments at such levels, much biological information
will be lost. A key feature of discussion from
the transcriptome work presented was whether
microarray data required validation by other meth-
ods, such as RT–PCR. Clearly, not all genes can be
validated in this way, but target genes for further
studies (such as making mutants) should be tested,
despite the good correlation that is now accepted
between microarray data and quantitative RT–PCR
or Northern blotting. Good statistical analysis of
array data is of primary importance, but this is lim-
ited by biological and experimental variation and
the number of replicates: ‘One array does not a
summer make!’.
Data analysis
Such considerations led on to the part of the meet-
ing on data analysis, where variation in data and
how to extract meaningful information were the
main themes. Variation in microarray experiments
exists at different levels: biological, experimental,
analytical (image and data analysis) and interpreta-
tive. Experimental design from the statistical view
and the need to randomize both experimental set-up
and the microarray format itself, were considered
important. Ways to optimize the number of repli-
cates (biological and experimental) required for
robust statistical validity of data (Wernisch, p. 372)
and approaches to data visualization and mathe-
matical modelling of array data sets (Wolkenhauer
et al., p. 375) were also presented. Well-designed
microarray experiments require close and contin-
ued association of statistician, biologist and math-
ematician. This meeting exempliﬁed such a collab-
orative approach to bacterial functional genomics
and exposed data analysis as a major bottleneck. In
the context of facilitating microarray data handling
and interrogation, a microarray relational database
created by Dr Adam Witney from BµG@S was
demonstrated. This database, called BµG@Sbase,
enables all aspects of the construction of a partic-
ular array to be viewed from gene sequence, PCR
primer pairs, PCR product gel electrophoresis, to
array format with spot identity enquiry (Witney
and Hinds, p. 369). Development of the database
to include experimental data and integrate analysis
tools will ultimately enable the full repertoire of
microarray data handling and analysis to be accom-
plished from a single computer format.
Summary
Perhaps the most signiﬁcant feature of the meeting
was the fact that so many people were describ-
ing experiments they had done, and the signiﬁ-
cance of the results, as well as the problems they
had encountered. This contrasts with many meet-
ings to date, where talks have mostly discussed
array production and experiments that are planned.
However, microarray experimental systems are an
emerging and rapidly developing technology and
thus still have limitations and pitfalls. This meeting
set out to explore such limitations in the hope that
sharing experiences in a collaborative environment
would allow collective progress towards develop-
ment of robust technical protocols and data analysis
tools. Despite limitations, widespread availability
and use of DNA microarrays in the current for-
mat for small genomes are now of undisputed
biological utility. BµG@S is an example of a func-
tional genomics resource for multi-collaborative
networks of research groups and can act as a model
for functional genomics initiatives for more com-
plex organisms (e.g. humans). The meeting showed
how microarray technology can address both fun-
damental and applied issues in pathogen biology:
from comparative genome organization through to
studies on pathogenesis, virulence genes, molec-
ular epidemiology and public health. We should
now look forward to exploiting these microar-
ray resources and expanding the multi-disciplinary
institutional and personal collaborations necessary
for rapid progress in bacterial functional genomics.
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